GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
134 hedge funds and large institutions have $1.03B invested in Global Blood Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 64 increasing their positions, 25 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $1.16B → $1.03B (-$127M)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
134
Holding in Top 10
5
Calls
$14M
Puts
$9.27M
Top Buyers
| 1 | +$40.1M | |
| 2 | +$29.7M | |
| 3 | +$26.9M | |
| 4 |
BlackRock
New York
|
+$21.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$16.6M |
Top Sellers
| 1 | -$53.6M | |
| 2 | -$10.1M | |
| 3 | -$8.29M | |
| 4 |
YCMGA
York Capital Management Global Advisors
New York
|
-$4.24M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.51M |